Literature DB >> 18516053

Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms.

Christoph Buettner1, Evan D Muse, Andrew Cheng, Linghong Chen, Thomas Scherer, Alessandro Pocai, Kai Su, Bob Cheng, Xiasong Li, Judith Harvey-White, Gary J Schwartz, George Kunos, Luciano Rossetti, Christoph Buettner1.   

Abstract

Leptin (encoded by Lep) controls body weight by regulating food intake and fuel partitioning. Obesity is characterized by leptin resistance and increased endocannabinoid tone. Here we show that leptin infused into the mediobasal hypothalamus (MBH) of rats inhibits white adipose tissue (WAT) lipogenesis, which occurs independently of signal transducer and activator of transcription-3 (STAT3) signaling. Correspondingly, transgenic inactivation of STAT3 signaling by mutation of the leptin receptor (s/s mice) leads to reduced adipose mass compared to db/db mice (complete abrogation of leptin receptor signaling). Conversely, the ability of hypothalamic leptin to suppress WAT lipogenesis in rats is lost when hypothalamic phosphoinositide 3-kinase signaling is prevented or when sympathetic denervation of adipose tissue is performed. MBH leptin suppresses the endocannabinoid anandamide in WAT, and, when this suppression of endocannabinoid tone is prevented by systemic CB1 receptor activation, MBH leptin fails to suppress WAT lipogenesis. These data suggest that the increased endocannabinoid tone observed in obesity is linked to a failure of central leptin signaling to restrain peripheral endocannabinoids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516053      PMCID: PMC2671848          DOI: 10.1038/nm1775

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  50 in total

Review 1.  Regulation of adipogenesis and energy balance by PPARgamma and PGC-1.

Authors:  B M Spiegelman; P Puigserver; Z Wu
Journal:  Int J Obes Relat Metab Disord       Date:  2000-11

Review 2.  Mechanisms of nutritional and hormonal regulation of lipogenesis.

Authors:  S Kersten
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

3.  Intracellular signalling. Key enzyme in leptin-induced anorexia.

Authors:  K D Niswender; G J Morton; W H Stearns; C J Rhodes; M G Myers; M W Schwartz
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

4.  Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars.

Authors:  I A Potapova; M R El-Maghrabi; S V Doronin; W B Benjamin
Journal:  Biochemistry       Date:  2000-02-08       Impact factor: 3.162

5.  Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.

Authors:  Isabel Matias; Marie-Paule Gonthier; Pierangelo Orlando; Vassilis Martiadis; Luciano De Petrocellis; Cristina Cervino; Stefania Petrosino; Laurence Hoareau; Franck Festy; Renato Pasquali; Regis Roche; Mario Maj; Uberto Pagotto; Palmiero Monteleone; Vincenzo Di Marzo
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

6.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

Review 7.  Leptin: an essential regulator of lipid metabolism.

Authors:  S P Reidy; J Weber
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2000-03       Impact factor: 2.320

8.  Leptin-specific patterns of gene expression in white adipose tissue.

Authors:  A Soukas; P Cohen; N D Socci; J M Friedman
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

9.  The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.

Authors:  T Yamauchi; J Kamon; H Waki; K Murakami; K Motojima; K Komeda; T Ide; N Kubota; Y Terauchi; K Tobe; H Miki; A Tsuchida; Y Akanuma; R Nagai; S Kimura; T Kadowaki
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

10.  The central melanocortin system can directly regulate serum insulin levels.

Authors:  W Fan; D M Dinulescu; A A Butler; J Zhou; D L Marks; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

View more
  135 in total

Review 1.  Bariatric surgery and the central nervous system.

Authors:  Raghavendra S Rao
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

Review 2.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

3.  The HPA axis modulates the CNS melanocortin control of liver triacylglyceride metabolism.

Authors:  Petra Wiedmer; Nilika Chaudhary; Michaela Rath; Chun-Xia Yi; Gayathri Ananthakrishnan; Rubén Nogueiras; Eva K Wirth; Henriette Kirchner; Ulrich Schweizer; Wenke Jonas; Christelle Veyrat-Durebex; Francoise Rohner-Jeanrenaud; Annette Schürmann; Hans-Georg Joost; Matthias H Tschöp; Diego Perez-Tilve
Journal:  Physiol Behav       Date:  2011-10-28

4.  Brain insulin controls adipose tissue lipolysis and lipogenesis.

Authors:  Thomas Scherer; James O'Hare; Kelly Diggs-Andrews; Martina Schweiger; Bob Cheng; Claudia Lindtner; Elizabeth Zielinski; Prashant Vempati; Kai Su; Shveta Dighe; Thomas Milsom; Michelle Puchowicz; Ludger Scheja; Rudolf Zechner; Simon J Fisher; Stephen F Previs; Christoph Buettner
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

5.  The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release.

Authors:  Blerina Kola; Gábor Wittman; Ibolya Bodnár; Faisal Amin; Chung Thong Lim; Márk Oláh; Mirjam Christ-Crain; Francesca Lolli; Hinke van Thuijl; Chrysanthia A Leontiou; Tamás Füzesi; Paolo Dalino; Andrea M Isidori; Judith Harvey-White; George Kunos; György M Nagy; Ashley B Grossman; Csaba Fekete; Márta Korbonits
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

6.  iBAT sympathetic innervation is not required for body weight loss induced by central leptin delivery.

Authors:  Isabelle Côté; Yasemin Sakarya; Sara M Green; Drake Morgan; Christy S Carter; Nihal Tümer; Philip J Scarpace
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-31       Impact factor: 4.310

Review 7.  Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies.

Authors:  Janine J Geerling; Mariëtte R Boon; Sander Kooijman; Edwin T Parlevliet; Louis M Havekes; Johannes A Romijn; Illiana M Meurs; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2013-11-27       Impact factor: 5.922

Review 8.  The dysregulation of the endocannabinoid system in diabesity-a tricky problem.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  J Mol Med (Berl)       Date:  2009-03-17       Impact factor: 4.599

Review 9.  Hormone and glucose signalling in POMC and AgRP neurons.

Authors:  Bengt F Belgardt; Tomoo Okamura; Jens C Brüning
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

10.  Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.

Authors:  Joseph Tam; Resat Cinar; Jie Liu; Grzegorz Godlewski; Daniel Wesley; Tony Jourdan; Gergő Szanda; Bani Mukhopadhyay; Lee Chedester; Jeih-San Liow; Robert B Innis; Kejun Cheng; Kenner C Rice; Jeffrey R Deschamps; Robert J Chorvat; John F McElroy; George Kunos
Journal:  Cell Metab       Date:  2012-07-26       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.